Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers. | J Mol Med (Berl) | 2022 | 35915349 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population. | Front Genet | 2022 | 35910207 | PubTator, text mining | PubMed |
| Viral-host interactions during splicing and nuclear export of influenza virus mRNAs. | Curr Opin Virol | 2022 | 35908311 | PubTator, text mining | PubMed |
| Myasthenia gravis complicating the surgical management of achondroplasia: a case-based update. | Childs Nerv Syst | 2022 | 35908138 | PubTator, text mining | PubMed |
| Molecular mechanisms and clinical applications of exosomes in prostate cancer. | Biomark Res | 2022 | 35906674 | PubTator, text mining | PubMed |
| The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention. | Int J Mol Sci | 2022 | 35897717 | PubTator, text mining | PubMed |
| Actin nano-architecture of phagocytic podosomes. | Nat Commun | 2022 | 35896550 | PubTator, text mining | PubMed |
| The Identification by Exome Sequencing of Candidate Genes in BRCA-Negative Tunisian Patients at a High Risk of Hereditary Breast/Ovarian Cancer. | Genes (Basel) | 2022 | 35893033 | PubTator, text mining | PubMed |
| Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions. | Antibodies (Basel) | 2022 | 35892709 | PubTator, text mining | PubMed |
RNA Sequencing Reveals the Expression Profiles of circRNAs and Indicates Hsa_circ_0070562 as a Pro-osteogenic Factor in Bone Marrow-Derived Mesenchymal Stem Cells of Patients With Ankylosing Spondylitis. | Front Genet | 2022 | 35873481 | PubTator, text mining | PubMed |
| Cancer genes and cancer stem cells in tumorigenesis: Evolutionary deep homology and controversies. | Genes Dis | 2022 | 35873035 | PubTator, text mining | PubMed |
| Identification of human mitochondrial RNA cleavage sites and candidate RNA processing factors. | BMC Biol | 2022 | 35869520 | PubTator, text mining | PubMed |
| Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines. | Mol Cell Proteomics | 2022 | 35863698 | PubTator, text mining | PubMed |
| An Actin-, Cortactin- and Ena-VASP-Linked Complex Contributes to Endothelial Cell Focal Adhesion and Vascular Barrier Regulation. | Cell Physiol Biochem | 2022 | 35856787 | PubTator, text mining | PubMed |
| Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer. | NPJ Precis Oncol | 2022 | 35853934 | PubTator, text mining | PubMed |
| Respiratory syncytial virus disrupts the airway epithelial barrier by decreasing cortactin and destabilizing F-actin. | J Cell Sci | 2022 | 35848790 | PubTator, text mining | PubMed |
| Quantitative Analysis of the Protein Methylome Reveals PARP1 Methylation is involved in DNA Damage Response. | Front Mol Biosci | 2022 | 35847980 | PubTator, text mining | PubMed |
| SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. | Front Immunol | 2022 | 35844544 | PubTator, text mining | PubMed |
| Biomechanical microenvironment in peripheral nerve regeneration: from pathophysiological understanding to tissue engineering development. | Theranostics | 2022 | 35836812 | PubTator, text mining | PubMed |
| Steering the multipotent mesenchymal cells towards an anti-inflammatory and osteogenic bias via photobiomodulation therapy: How to kill two birds with one stone. | J Tissue Eng | 2022 | 35832724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=31